Analyst Adam Jonas lowered his price target on shares to $410 from $430, citing lower delivery projections for Tesla.
Related Posts
FDA says Eli Lilly’s weight loss drug Zepbound is no longer in shortage
The decision that will eventually bar compounding pharmacies from making unbranded versions of the injection.
Trump administration accused of sidestepping court rulings amid spree of legal losses
Trump’s efforts to drastically shrink the size of the federal government are running into legal roadblocks.
Spirit Airlines stock jumps 25% after struggling budget carrier said it will sell planes, cut jobs
Spirit Airlines shares rose after the struggling carrier said it will cut jobs and sell planes.